Arca
Skip to content
Tools
Tools

Agfa HealthCare Enterprise Imaging XERO Viewer

Recall Z-1004-2023, part of FDA recall event 91357. See Agfa HealthCare's company page.

Agfa Healthcare NV started this Class II device recall on Dec 5, 2022 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: Dec 5, 2022
  • Status: Ongoing

Why It Was Recalled

Class II

There is a software defect that can cause issues with images.

Record

Product
Agfa HealthCare Enterprise Imaging XERO Viewer
Quantity
110 units
Lots and codes
Affected software versions include: XERO Viewer 8.1.4.100 or higher XERO Viewer 8.2.0.000 or higher XERO Viewer 8.2.1.000 or higher UDI/DI: 05400874000710
Distribution
Distribution throughout US OUS distribution to Australia, Belgium, Brazil, Canada, Chile, Cyprus, France, Iceland, Ireland, Italy, Kenya, Luxembourg, Netherlands, Romania, Saudi Arabia, Spain, Sweden, United Kingdom, South Africa
Recalling firm
Agfa Healthcare NV, Mortsel, N/A, Belgium
How the firm notified
Letter
FDA classified
Jan 20, 2023

Agfa Healthcare NV's Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.